Educational Objectives


By the end of the 5-day educational program, the participants will be able to:

  • appreciate the epidemiology and the impact of thrombosis and venous thromboembolism (VTE)
  • translate the knowledge from experimental research (in vitro and in vivo models) to the pathomechanisms of acute and chronic VTE in humans
  • identify the predisposing factors for VTE in different patient populations
  • understand the association between thrombosis and cancer, and its implications for clinical practice
  • employ scores and prediction rules in the diagnosis of VTE
  • assess and define the severity of acute VTE and the indications for advanced therapy (thrombolysis, surgical embolectomy, catheter-directed treatment, cava filter placement)
  • determine the appropriate management strategy in challenging cases and vulnerable patient populations, including VTE in pregnancy
  • gain deeper insight into the modalities, duration, and possible bleeding complications of anticoagulation
  • understand the role of the laboratory in the contemporary management of anticoagulated patients with VTE
  • implement guideline recommendations to the early detection, diagnosis and treatment of chronic thromboembolic pulmonary hypertension
  • correctly conduct and interpret right heart catheterization
  • evaluate the design and interpret the statistical analysis of clinical trials
  •  appreciate the contribution of large cohorts and biodata banking to state-of-the-art VTE research
  • network with international experts and early-stage researchers/physicians in the field of thrombosis and venous thromboembolism.